A
Auspex Pharmaceuticals
A biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases
At a glance
- Founded
- 2001
- Headquarters
- San Diego, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
- CCCMEA Capital
- DEDeerfield
- BVBioMed Ventures
- PCPanorama Capital
- TPThomas McNerney & Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former Auspex Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
MPMirum PharmaceuticalsEst. 2018
Mike GreyUnited States
SLSauce LabsEst. 2008
John DunhamUnited States
JPJazz PharmaceuticalsEst. 2003Global footprint
Patents
44 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Auspex Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Auspex Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.